Your browser doesn't support javascript.
loading
18F-FDG PET/MR-imaging in a Göttingen Minipig model of atherosclerosis: Correlations with histology and quantitative gene expression.
Ludvigsen, Trine P; Pedersen, Sune F; Vegge, Andreas; Ripa, Rasmus S; Johannesen, Helle H; Hansen, Adam E; Löfgren, Johan; Schumacher-Petersen, Camilla; Kirk, Rikke K; Pedersen, Henrik D; Christoffersen, Berit Ø; Ørbæk, Mathilde; Forman, Julie L; Klausen, Thomas L; Olsen, Lisbeth H; Kjaer, Andreas.
Affiliation
  • Ludvigsen TP; Global Drug Discovery, Novo Nordisk Park, Novo Nordisk A/S, DK-2760, Måløv, Denmark.
  • Pedersen SF; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Vegge A; Global Drug Discovery, Novo Nordisk Park, Novo Nordisk A/S, DK-2760, Måløv, Denmark.
  • Ripa RS; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Johannesen HH; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Hansen AE; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Löfgren J; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Schumacher-Petersen C; Department of Veterinary and Animal Sciences, University of Copenhagen, Ridebanevej 9, DK-1870, Frederiksberg, Denmark.
  • Kirk RK; Global Drug Discovery, Novo Nordisk Park, Novo Nordisk A/S, DK-2760, Måløv, Denmark.
  • Pedersen HD; Department of Veterinary and Animal Sciences, University of Copenhagen, Ridebanevej 9, DK-1870, Frederiksberg, Denmark; Ellegaard Göttingen Minipigs A/S, Sorø Landevej 302, DK-4261, Dalmose, Denmark.
  • Christoffersen BØ; Global Drug Discovery, Novo Nordisk Park, Novo Nordisk A/S, DK-2760, Måløv, Denmark.
  • Ørbæk M; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Forman JL; Section of Biostatistics, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK-1014, Copenhagen, Denmark.
  • Klausen TL; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
  • Olsen LH; Department of Veterinary and Animal Sciences, University of Copenhagen, Ridebanevej 9, DK-1870, Frederiksberg, Denmark.
  • Kjaer A; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Dept. of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. Electronic address: akjaer@sund.ku.dk.
Atherosclerosis ; 285: 55-63, 2019 06.
Article in En | MEDLINE | ID: mdl-31004968
BACKGROUND AND AIMS: The advantage of combining molecular and morphological imaging, e.g. positron emission tomography and magnetic resonance imaging (PET/MRI), is reflected in the increased use of these modalities as surrogate end-points in clinical trials. This study aimed at evaluating plaque inflammation using 18F-fluorodeoxyglucose (18F-FDG)-PET/MRI, and gene expression in a minipig model of atherosclerosis. METHODS: Göttingen Minipigs were fed for 60 weeks with fat/fructose/cholesterol-rich diet (FFC), chow (Control) or FFC-diet changed to chow midway (diet normalization group; DNO). In all groups, 18F-FDG-PET/MRI of the abdominal aorta was assessed midway and at study-end. The aorta was analyzed using histology and gene expression. RESULTS: At study-end, FFC had significantly higher FDG-uptake compared to Control (target-to-background maximal uptake, TBRMax (95% confidence interval) CITBRMax: 0.092; 7.32) and DNO showed significantly decreased uptake compared to FFC (CITBRMax: -5.94;-0.07). No difference was observed between DNO and Control (CITBRMax: -2.71; 4.11). FFC displayed increased atherosclerosis and gene expression of inflammatory markers, including vascular cell adhesion molecule 1 (VCAM-1), cluster of differentiation 68 (CD68), matrix metalloproteinase 9 (MMP9), cathepsin K (CTSK) and secreted phosphoprotein 1 (SPP1) compared to Control and DNO (all, p < 0.05). FDG-uptake correlated with gene expression of inflammatory markers, including CD68, ρs = 0.58; MMP9, ρs = 0.46; SPP1, ρs = 0.44 and CTSK, ρs = 0.49; (p ≤ 0.01 for all). CONCLUSIONS: In a model of atherosclerosis, 18F-FDG-PET/MRI technology allows for detection of inflammation in atherosclerotic plaques, consistent with increased inflammatory gene expression. Our findings corroborate clinical data and are important in pre-clinical drug development targeting plaque inflammation.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Atherosclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Atherosclerosis Year: 2019 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Atherosclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Atherosclerosis Year: 2019 Document type: Article Affiliation country: Country of publication: